88 related articles for article (PubMed ID: 3162138)
1. [Influence of technical factors in the determination of minimal inhibitory concentration by microdilution].
Forey F; Coulet M; Brun Y; Fleurette J
Pathol Biol (Paris); 1985 May; 33(5):341-9. PubMed ID: 3162138
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Ronco E; Pilliot J
Pathol Biol (Paris); 1985 May; 33(5):381-4. PubMed ID: 3162139
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
5. Regression analyses for cefoperazone on Mueller-Hinton agar and DST agar.
Langmaack H; Daschner F
Clin Ther; 1980; 3(Spec Issue):123-6. PubMed ID: 6446384
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
7. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
8. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
[TBL] [Abstract][Full Text] [Related]
10. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems.
Mizunaga S; Kamiyama T; Fukuda Y; Takahata M; Mitsuyama J
J Antimicrob Chemother; 2005 Jul; 56(1):91-6. PubMed ID: 15890721
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of enoxacin compared with norfloxacin and amikacin.
van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
13. [Results of two methods for testing bacterial susceptibility to antibiotics: disk method and a new semi-automatic method in liquid medium (ABACR procedure) and comparison with the minimal inhibitory concentration (author's transl)].
Véron M; Ghnassia JC; Berche P; Daoulas-Le Bourdellès F; Avril JL; Fauchère JL; de Meirleire F; Descamps P
Ann Microbiol (Paris); 1978; 129(4):473-502. PubMed ID: 100035
[TBL] [Abstract][Full Text] [Related]
14. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of norfloxacin.
Norrby SR; Jonsson M
Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of norfloxacin against Enterobacteriaceae and Pseudomonas aeruginosa.
García-Rodríguez JA; Gómez-García AC; Rodrigo N
J Antimicrob Chemother; 1984 Aug; 14(2):192-3. PubMed ID: 6238928
[No Abstract] [Full Text] [Related]
17. [Antibiotic susceptibility testing by the disk method. Comparative evaluation of 5 commercial systems].
Margalejo H; Brun Y; Messy P; Fleurette J
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):483-7. PubMed ID: 6431378
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
19. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
Tenney JH; Maack RW; Chippendale GR
Antimicrob Agents Chemother; 1983 Jan; 23(1):188-9. PubMed ID: 6219620
[TBL] [Abstract][Full Text] [Related]
20. Criteria for the interpretation of the pipemidic acid agar diffusion test by the Kirby-Bauer method.
Grimm H
Arzneimittelforschung; 1983; 33(7):913-5. PubMed ID: 6414487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
